Replies to post #27603 on Humanigen Inc (fka HGENQ)

[MWM]

The buyout is coming...

[Knuckle Sandwich]

I love seeing more attention for Lenzilumab in Car-T. This seems to get completely overlooked with Covid, but Zuma-19 is on pace to provide Phase-I data in Q-2, and Phase II interim Data in Q-4. Currently active in 10 prestigious Hospitals.

Phase III may not be necessary for approval in ZUMA-19; precedent is CAR-Ts to date have been approved on Phase II data

https://www.humanigen.com/pipeline


Original Plans included studies with Novartis Kymriah. Now we also have Bristol Myers Squibb Breyanzi, a CAR-T treatment for diffuse large B-cell lymphoma.


https://medcitynews.com/2021/03/bristol-myers-squibb-wins-first-car-t-therapy-approval-in-multiple-myeloma/





https://clinicaltrials.gov/ct2/show/NCT04314843?id=NCT04351152+OR+NCT04314843+OR+NCT03374943+OR+NCT04534725+OR+NCT04583969+OR+NCT04583956&draw=2&rank=5&load=cart

Locations

Stanford University Recruiting


Moffitt Cancer Center Recruiting


Northwestern University Recruiting

Mayo Clinic Recruiting

Roswell Park Cancer Institute Recruiting

Columbia University Medical Center, New York-Presbyterian Hospital

Recruiting

Levine Cancer Center Recruiting

Oregon Health & Science University Recruiting

Vanderbilt University Recruiting

MD Anderson Cancer Center Recruiting